Cargando…
Impact of COVID-19 Pandemic on Non-Small Cell Lung Cancer Care
We assessed the impact of COVID-19 on healthcare visits, timing of stage IV NSCLC diagnosis and immunotherapy initiation, and rates of switching to extended dosing schedules of immunotherapies among patients with stage IV NSCLC. This retrospective study examined electronic health record data of adul...
Autores principales: | Zhai, YiYuan, Chopra, Pooja, Kang, David, Robert, Nicholas J., Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858327/ https://www.ncbi.nlm.nih.gov/pubmed/36661708 http://dx.doi.org/10.3390/curroncol30010059 |
Ejemplares similares
-
PCN3 IMPACT of COVID-19 on Immunotherapy Utilization in Metastatic NON-SMALL Cell LUNG Cancer
por: Chopra, P., et al.
Publicado: (2020) -
Impact of the COVID-19 pandemic on non–small-cell lung cancer pathologic stage and presentation
por: Keogh, Joshua A.J., et al.
Publicado: (2022) -
Diagnostic accuracy of computed tomography imaging for the detection of differences between peripheral small cell lung cancer and peripheral non-small cell lung cancer
por: Ren, Yanchen, et al.
Publicado: (2017) -
The Impact of COVID-19 Pandemic on Surgical Treatment of Resectable Non-Small Cell Lung Cancer in Greece
por: Tomos, Ioannis, et al.
Publicado: (2023) -
Role of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer in the COVID-19 Pandemic
por: Karaman, Elanur, et al.
Publicado: (2022)